The biotechnology market is expected to show substantial growth over the forecast period owing to regulatory support offered to various companies operating in the biotechnology field. In addition, the increased demand for food in developing countries has spurred the growth of the bioagriculture market. Bioseeds are expected to show exponential growth as compared to conventional seeds over the forecast period.

This report on the biotechnology market analyzes and estimates the global revenue generated by the biotechnology industry over the forecast period i.e. 2012 to 2017. The scope of the report considers biotechnology to be divided into four primary segments namely biopharmacy, bioservices, bioagriculture and bioindustrial. In terms of technology, the biotechnology market has been segmented into fermentation, tissue regeneration, PCR technology, nanobiotechnology, chromatography, DNA sequencing, cell based assay and others. The others segment comprises of genetic engineering, enzyme technology and fingerprinting among others.

Biopharmacy comprises of various pharmaceuticals manufactured by using biotechnology and also covers medical devices. The bioservices segment predominantly comprises of CROs (Contract Research Organizations) which are third party organizations performing clinical trials, drug discovery and contract manufacturing. The bioindustrial application includes the use of bioenzymes and biochemicals for a variety of chemical processes. Bioagriculture comprises of bioseeds and genetically modified (GM) crops.

The study explains the various drivers and restraints affecting the market along with the impact they would have over the forecast period. A detailed analysis of the opportunities available in the market over the next five years has also been included. The value chain for the biotechnology market has been provided for a better understanding of the process followed in the market. The study covers in detail the Porters Five Forces analysis, which gives the users of this report a better perspective into the present and future market scenarios. The market has been segmented based on technology, application and geography. Apart from the global application overview, the report further segregates the applications for regions such as North America, Europe, Asia Pacific and Rest of the World (RoW).

Key market players in the report include Roche, Amgen, Novo Nordisk, Sanofi and Pfizer among others. A detailed company market share has been included to give a better understanding of the competitive situation in the market. In addition, these companies have been profiled with respect to attributes such as company overview, financial overview, SWOT analysis, business strategy and recent developments.

The report provides a cross-sectional analysis of all the above applications with respect to the following geographical markets:

North America
Europe
Asia Pacific
Rest of the World (RoW)
The detailed analysis and research will help biotechnology companies, retailers and R&D institutes to make well-informed decisions about manufacturing, marketing and sales and in turn help them gain competitive advantage.

The US biotechnology market(http://www.researchmoz.us/the-us-biotechnology-market-outlook-to-2016-future-growth-led-by-surging-biotech-application-in-agriculture-health-and-industrial-sector-report.html) can be classified into three segments- Bio-Pharma, Industrial biotechnology and Agricultural biotechnology. The bio-pharma represents the largest segment in the US biotechnology market. This is followed by industrial biotechnology which is the second largest contributor in the US biotechnology market. Biologic drugs are gradually increasing their share over the period. Biological drugs are generally more expensive than the conventional drugs thus acting as a key revenue earners for producers. The total US biologic drugs market grew from USD ~ billion in 2006 to USD ~ billion in 2011 at a 5 year CAGR of 7.7%. Biologic drugs has high potential for future growth because of better long term outcomes with fewer costly side effects. Bristol-Myers Squibb is the largest company in the US in terms of biopharmaceutical drugs sales. The company held a market share of ~% and recorded sales of USD ~ billion. The company focuses on developing drugs in the oncology therapeutic class.